Abstract
The plants, Althaea officinalis, Tilia cordata and Psidium guaja have been used traditionally to treat respiratory infection symptoms. Flowers of A. officinalis and leaves of T. cordata and P. guaja have been used to treat cough, sore throat, catarrh, oral and pharyngeal mucosa irritation. Therefore, this study was designed to examine the antibacterial and antibiofilm effects of these plants individually as well as in combination, as a formula against respiratory infections causing pathogens. The tested pathogens were Extended Spectrum Beta-Lactamase producing Escherichia coli (ESBL), Beta-Lactamase producing Escherichia coli (BL), Beta-Lactamase producing Klebsiella pneumoniae (BL), Beta-Lactamase producing Pseudomonas aeruginosa (BL), Enterobacter cloacae, and Beta-Lactamase producing Staphylococcus aureus (BL). The tested plants were extracted using ethanol and then fractionated using different polarity solvents (hexane, ethyl acetate and water). Disc diffusion and microdilution (Minimum Inhibitory Concentration) methods were used to evaluate the antibacterial activity while the antibiofilm activity was tested using crystal violet assay. The results showed that A. officinalis and T. cordata extracts and fractions exhibited weak antibacterial activity having MIC values ranged from 6.25 to 12.5 mg/mL. P. guaja exhibited moderate antibacterial activity with MIC values ranged from 6.25 to 1.56 mg/mL. Combination between these plants extracts and fractions in equal proportion provides stronger antibacterial (with MIC values ranged from 6.25 to 0.8 mg/mL) and antibiofilm activities (MBIC50 was 0.2 mg/mL). Therefore, this study provides a valuable scientific knowledge to support the use of plants in combination rather than individually.
Highlights
Respiratory infections are considered as the most common infection worldwide
Epiglottitis and bronchitis are frequently caused by Haemophilus influenzae type b, Corynebacterium diphtheria, Streptococcus pneumoniae and Mycoplasma pneumoniae
Pneumonia is caused by such agents as Streptococcus pneumoniae, Staphylococcus aureus, Streptococcus pyogenes, Haemophilus influenzae, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa and Mycobacterium tuberculosis.[5]
Summary
More than 50 million deaths are reported every year due to infections related to respiratory system.[1,2] The respiratory infections could be caused by several pathogenic agents including viruses and bacteria.[3,4] In case of bacterial infections, most common causative agents for pharyngitis and tonsillitis are Group A Beta Hemolytic Streptococci, Corynebacterium diphtheria and Neisseria gonorrhoeae. Epiglottitis and bronchitis are frequently caused by Haemophilus influenzae type b, Corynebacterium diphtheria, Streptococcus pneumoniae and Mycoplasma pneumoniae. Pneumonia is caused by such agents as Streptococcus pneumoniae, Staphylococcus aureus, Streptococcus pyogenes, Haemophilus influenzae, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa and Mycobacterium tuberculosis.[5] a steady increase in the frequency of antibiotics resistant bacteria implicated in Citation: Qaralleh H, Al-Limoun MO, Khlaifat A, Khleifat KM, AlTawarah N, Alsharafa KY, Abu-Harirah HA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.